ImmunoPrecise Antibodies
IPA
$1.00
Share price
0.00%
Change (1 day)
-68.25%
Change (1 year)
Categories
Revenue for ImmunoPrecise Antibodies (IPA)
Revenue in 2023 (TTM): $16.74 M
According to ImmunoPrecise Antibodies's latest financial reports the company's current revenue (TTM
) is $17.52 M.
In 2022 the company made a revenue of $15.31 M an increase over the years 2021 revenue that were of $14.99 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for ImmunoPrecise Antibodies from 2009 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $16.74 M | 9.34% |
| 2022 | $15.31 M | 2.17% |
| 2021 | $14.99 M | 20.86% |
| 2020 | $12.4 M | 46.25% |
| 2019 | $8.48 M | 19.74% |
| 2018 | $7.08 M | 204.51% |
| 2017 | $2.32 M | |
| 2015 | N/A | |
| 2014 | N/A | |
| 2013 | N/A | |
| 2012 | N/A | |
| 2011 | N/A | |
| 2010 | N/A | |
| 2009 | N/A |